Advancing assessment of asthma control with a composite tool
Open Access
- 16 March 2024
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 133 (1) , 49-56
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma ExacerbationsThe Journal of Allergy and Clinical Immunology: In Practice, 2022
- Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recallAnnals of Allergy, Asthma & Immunology, 2022
- Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control MeasureThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Shared decision making for the allergistAnnals of Allergy, Asthma & Immunology, 2019
- Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United StatesThe Journal of Allergy and Clinical Immunology: In Practice, 2015
- Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyJournal of Allergy and Clinical Immunology, 2012
- Recent asthma exacerbations: A key predictor of future exacerbationsRespiratory Medicine, 2007
- Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialistsJournal of Allergy and Clinical Immunology, 2006
- Development of the asthma control testJournal of Allergy and Clinical Immunology, 2004